Correlation Between BioXcel Therapeutics and Sana Biotechnology
Can any of the company-specific risk be diversified away by investing in both BioXcel Therapeutics and Sana Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BioXcel Therapeutics and Sana Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BioXcel Therapeutics and Sana Biotechnology, you can compare the effects of market volatilities on BioXcel Therapeutics and Sana Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BioXcel Therapeutics with a short position of Sana Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of BioXcel Therapeutics and Sana Biotechnology.
Diversification Opportunities for BioXcel Therapeutics and Sana Biotechnology
0.09 | Correlation Coefficient |
Significant diversification
The 3 months correlation between BioXcel and Sana is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding BioXcel Therapeutics and Sana Biotechnology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sana Biotechnology and BioXcel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BioXcel Therapeutics are associated (or correlated) with Sana Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sana Biotechnology has no effect on the direction of BioXcel Therapeutics i.e., BioXcel Therapeutics and Sana Biotechnology go up and down completely randomly.
Pair Corralation between BioXcel Therapeutics and Sana Biotechnology
Given the investment horizon of 90 days BioXcel Therapeutics is expected to generate 1.29 times more return on investment than Sana Biotechnology. However, BioXcel Therapeutics is 1.29 times more volatile than Sana Biotechnology. It trades about -0.23 of its potential returns per unit of risk. Sana Biotechnology is currently generating about -0.39 per unit of risk. If you would invest 67.00 in BioXcel Therapeutics on August 29, 2024 and sell it today you would lose (21.00) from holding BioXcel Therapeutics or give up 31.34% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
BioXcel Therapeutics vs. Sana Biotechnology
Performance |
| Timeline |
| BioXcel Therapeutics |
| Sana Biotechnology |
BioXcel Therapeutics and Sana Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with BioXcel Therapeutics and Sana Biotechnology
The main advantage of trading using opposite BioXcel Therapeutics and Sana Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BioXcel Therapeutics position performs unexpectedly, Sana Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sana Biotechnology will offset losses from the drop in Sana Biotechnology's long position.| BioXcel Therapeutics vs. Terns Pharmaceuticals | BioXcel Therapeutics vs. Amylyx Pharmaceuticals | BioXcel Therapeutics vs. Acumen Pharmaceuticals | BioXcel Therapeutics vs. Inozyme Pharma |
| Sana Biotechnology vs. Olema Pharmaceuticals | Sana Biotechnology vs. Cullinan Oncology LLC | Sana Biotechnology vs. Zentalis Pharmaceuticals Llc | Sana Biotechnology vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |